PLA2G16 Antikörper (AA 68-162)

Produktnummer ABIN7267786

Produktdetails anti-PLA2G16 Antikörper

Target: PLA2G16 (HRAS-Like Suppressor 3 (PLA2G16))

Bindungsspezifität: AA 68-162

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PLA2G16 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Verwendungszweck: PLA2G16 Rabbit pAb

Sequenz: VAGSDKYQVN NKHDDKYSPL PCSKIIQRAE ELVGQEVLYK LTSENCEHFV NELRYGVARS DQVRDVIIAA SVAGMGLAAM SLIGVMFSRN KRQKQ

Kreuzreaktivität: Human

Produktmerkmale: Polyclonal Antibodies

Aufreinigung: Affinity purification

Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 68-162 of human PLA2G16 (NP_009000.2).

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB,1:500 - 1:2000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Avoid freeze / thaw cycles.

Details zu PLA2G16

Target: PLA2G16 (HRAS-Like Suppressor 3 (PLA2G16))

Andere Bezeichnung: PLA2G16 (PLA2G16 Produkte)

Synonyme: HRASLS3 antikoerper, HREV107 antikoerper, HRSL3 antikoerper, AdPLA antikoerper, H-REV107-1 antikoerper, HREV107-1 antikoerper, HREV107-3 antikoerper, C78643 antikoerper, Hrasls3 antikoerper, Hrev107 antikoerper, MLP-3 antikoerper, phospholipase A2 group XVI antikoerper, phospholipase A2, group XVI antikoerper, PLA2G16 antikoerper, Pla2g16 antikoerper

Hintergrund: Exhibits both phospholipase A1/2 and acyltransferase activities. Shows phospholipase A1 (PLA1 and A2 (PLA2 activity, catalyzing the calcium-independent release of fatty acids from the sn-1 or sn-2 position of glycerophospholipids. For most substrates, PLA1 activity is much higher than PLA2 activity. Shows O-acyltransferase activity,catalyzing the transfer of a fatty acyl group from glycerophospholipid to the hydroxyl group of lysophospholipid. Shows N-acyltransferase activity, catalyzing the calcium-independent transfer of a fatty acyl group at the sn-1 position of phosphatidylcholine (PC and other glycerophospholipids to the primary amine of phosphatidylethanolamine (PE, forming N-acylphosphatidylethanolamine (NAPE, which serves as precursor for N-acylethanolamines (NAEs. Exhibits high N-acyltransferase activity and low phospholipase A1/2 activity. Required for complete organelle rupture and degradation that occur during eye lens terminal differentiation, when fiber cells that compose the lens degrade all membrane-bound organelles in order to provide lens with transparency to allow the passage of light. Organelle membrane degradation is probably catalyzed by the phospholipase activity (By similarity.,PLA2G16,AdPLA,H-REV107,H-REV107-1,HRASLS3,HREV107,HREV107-1,HREV107-3,HRSL3,Cancer,Tumor suppressors,PLA2G16

Molekulargewicht: 18kDa

Gen-ID: 11145

UniProt: P53816

Pathways: Inositol Metabolic Process